Additional alterations which lead to immune checkpoint inhibitor resistance are TGFβ-mediated downregulation of the expression of MHC class I molecules, decreased T-cell infiltration in the tumour, and loss of expression of melanoma differentiation antigens. This evidence concerns the gene TGFB1 and melanoma.